Health and Medicine
After the FDA’s approval, what to know about the new Alzheimer’s drug
Dr. Stephen Salloway, associate director of Brown’s new Center for Alzheimer’s Research who led clinical trials for the recently approved aducanumab, explained the key takeaways from the FDA’s headline-making decision.
Read Article